Stratpharma AG & Sensus Healthcare Announce Strategic Collaboration for Transformative Superficial Radiation Therapy & Post-Treatment Care
Collaboration Brings Sensus Healthcare’s SRT Technology and Stratpharma’s Wound Care Medical Devices Together to Advance Radiation Patient Outcomes SAN DIEGO, Oct. 23, 2017 — Stratpharma Inc. USA, a U.S. subsidiary of Stratpharma AG, the Swiss company that specializes in innovative film-forming full-contact topical medical products to improve medical and aesthetic outcomes in post-procedure care in […]
John Berry & Friends All Come Together for Hurricane Relief
John Berry & Friends All Come Together for Hurricane Relief!
Sensus Healthcare to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference
BOCA RATON, Fla., Oct. 11, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radiation Therapy (SRT), today announced that management will present at the Dawson James Securities 3rd Annual Small Cap Growth Conference on Thursday, October 19, 2017 at 12:00 […]
Sensus Healthcare to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference
BOCA RATON, Fla., Oct. 11, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radiation Therapy (SRT), today announced that management will present at the Dawson James Securities 3rd Annual Small Cap Growth Conference on Thursday, October 19, 2017 at 12:00 […]
Sensus Healthcare to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference
BOCA RATON, Fla., Oct. 11, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), today announced that management will present at the Dawson James Securities 3rd Annual Small Cap Growth Conference on Thursday, October 19, 2017 at 12:00 […]
Sensus Healthcare Details Abstract on Keloid Treatment with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting
BOCA RATON, Fla., Oct. 9, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radiation Therapy (SRT), announced today that an abstract was presented at the American Society for Dermatologic Surgery (ASDS) Annual Meeting, which took place on Oct. 5-8 in […]
Sensus Healthcare Details Abstract on Keloid Treatment with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting
BOCA RATON, Fla., Oct. 9, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radiation Therapy (SRT), announced today that an abstract was presented at the American Society for Dermatologic Surgery (ASDS) Annual Meeting, which took place on Oct. 5-8 in […]
Sensus Healthcare Details Abstract on Keloid Treatment with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting
BOCA RATON, Fla., Oct. 9, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), announced today that an abstract was presented at the American Society for Dermatologic Surgery (ASDS) Annual Meeting, which took place on Oct. 5-8 in […]
Sensus Healthcare Announces Abstract on Treatment of Keloids with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting
BOCA RATON, Fla., Oct. 9, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), announces that at the American Society for Dermatologic Surgery (ASDS) annual meeting, which took place October 5th-8th in Chicago, an abstract was presented illustrating […]
Sensus Healthcare Announces Abstract on Treatment of Keloids with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting
BOCA RATON, Fla., Oct. 9, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radiation Therapy (SRT), announces that at the American Society for Dermatologic Surgery (ASDS) annual meeting, which took place October 5th-8th in Chicago, an abstract was presented illustrating […]
